Cas:352431-23-3 4-(2H3)Methyl(2H6)aniline manufacturer & supplier

Chemical Name:4-(2H3)Methyl(2H6)aniline

CAS.NO:352431-23-3

Synonyms:p-Methylanilinium chloride;4-(H)Methyl(H)aniline;nonadeutero-4-toluidine;4-Methylanilinium chloride;4-Aminotoluene hydrochloride;4-methyl-aniline-hydrochloride;p-toluidine*HCl;4-methylbenzenaminium chloride;Benzen-2,3,5,6-d-amine-d, 4-(methyl-d)-;p-Me-PhNH2*HCl;P-TOLUIDINIUM CHLORIDE;p-Toluidine,hydrochloride;p-Me-C6H4-NH2*HCl

Molecular Formula:C₇D₉N

Molecular Weight:116.209

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:197.4±9.0 °C at 760 mmHg

Density:1.0±0.1 g/cm3

Index of Refraction:1.568

PSA:26.02000

Exact Mass:116.129990

LogP:1.40

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like p-Methylanilinium chloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,p-Me-C6H4-NH2*HCl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-(H)Methyl(H)aniline Use and application,4-methyl-aniline-hydrochloride technical grade,usp/ep/jp grade.

Related News: The Company��s first-of-kind approach involves engineering human iPSCs in a one-time genetic modification event and selecting a single engineered iPSC for maintenance as a clonal master iPSC line. 4-(2H3)Methyl(2H6)aniline manufacturer Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,�� Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement. 4-(2H3)Methyl(2H6)aniline supplier The data will be updated at the upcoming 2019 ASH Annual Meeting next week. 4-(2H3)Methyl(2H6)aniline vendor Huahai started with the development of characteristic APIs and pharmaceutical intermediates. At the same time, using the international cooperation platform and the opportunity of the expiry of patent protection of major international original research drugs, Huahai has extended the industrial chain to downstream high value-added preparations, and formed intermediates and materials The complete industrial chain of medicine and preparation integration. 4-(2H3)Methyl(2H6)aniline factory The Company��s first-of-kind approach involves engineering human iPSCs in a one-time genetic modification event and selecting a single engineered iPSC for maintenance as a clonal master iPSC line.